A business in context
MET research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-06-16 | Mumenthaler Christian Stephane | A · Grant / award | Common Stock | 587.0 | 87.4 |
| 2026-06-16 | Hay Laura J | A · Grant / award | Common Stock | 587.0 | 87.4 |
| 2026-06-16 | Seitz Michelle | A · Grant / award | Common Stock | 587.0 | 0.0 |
| 2026-06-16 | WEINBERGER MARK A | A · Grant / award | Common Stock | 587.0 | 0.0 |
| 2026-06-16 | MCKENZIE DIANA | A · Grant / award | Common Stock | 587.0 | 87.4 |
| 2026-06-16 | Johnson Jeh C. | A · Grant / award | Common Stock | 587.0 | 87.4 |
| 2026-06-16 | Harris Carla A | A · Grant / award | Common Stock | 587.0 | 87.4 |
| 2026-06-16 | Glaser Daniel S | A · Grant / award | Common Stock | 587.0 | 87.4 |
| 2026-06-16 | HUBBARD ROBERT GLENN | A · Grant / award | Common Stock | 1016.0 | 87.4 |
| 2026-06-16 | Kennard William E | A · Grant / award | Common Stock | 587.0 | 87.4 |
| 2026-06-09 | Mumenthaler Christian Stephane | A · Grant / award | Common Stock | 20.0 | 85.57 |
| 2026-06-09 | Hay Laura J | A · Grant / award | Common Stock | 39.0 | 85.57 |
| 2026-06-09 | MCKENZIE DIANA | A · Grant / award | Common Stock | 169.0 | 85.57 |
| 2026-06-09 | TADROS RAMY | A · Grant / award | Common Stock | 127.0 | 85.57 |
| 2026-06-09 | Johnson Jeh C. | A · Grant / award | Common Stock | 61.0 | 85.57 |
| 2026-06-09 | Harris Carla A | A · Grant / award | Common Stock | 42.0 | 85.57 |
| 2026-06-09 | Glaser Daniel S | A · Grant / award | Common Stock | 7.0 | 85.57 |
| 2026-06-09 | HUBBARD ROBERT GLENN | A · Grant / award | Common Stock | 678.0 | 85.57 |
| 2026-06-09 | Kennard William E | A · Grant / award | Common Stock | 322.0 | 85.57 |
| 2026-06-01 | DEBEL MARLENE | M · Exercise / conversion | Common Stock | 10600.0 | 46.85 |
| 2026-06-01 | DEBEL MARLENE | M · Exercise / conversion | Common Stock | 10712.0 | 45.5 |
| 2026-06-01 | DEBEL MARLENE | S · Sale | Common Stock | 21312.0 | 81.59 |
| 2026-06-01 | DEBEL MARLENE | M · Exercise / conversion | Employee Stock Options (right to buy) | 10712.0 | 0.0 |
| 2026-06-01 | DEBEL MARLENE | M · Exercise / conversion | Employee Stock Options (right to buy) | 10600.0 | 0.0 |
| 2026-04-30 | O'Neill Adrienne Karen | A · Grant / award | Common Stock | 12485.0 | — |
| 2026-04-01 | Mumenthaler Christian Stephane | A · Grant / award | Common Stock | 721.0 | 71.17 |
| 2026-04-01 | Hay Laura J | A · Grant / award | Common Stock | 721.0 | 71.17 |
| 2026-04-01 | Seitz Michelle | A · Grant / award | Common Stock | 721.0 | 0.0 |
| 2026-04-01 | WEINBERGER MARK A | A · Grant / award | Common Stock | 721.0 | 0.0 |
| 2026-04-01 | MCKENZIE DIANA | A · Grant / award | Common Stock | 721.0 | 71.17 |
| 2026-04-01 | Johnson Jeh C. | A · Grant / award | Common Stock | 721.0 | 71.17 |
| 2026-04-01 | Harris Carla A | A · Grant / award | Common Stock | 721.0 | 71.17 |
| 2026-04-01 | Glaser Daniel S | A · Grant / award | Common Stock | 721.0 | 71.17 |
| 2026-04-01 | HUBBARD ROBERT GLENN | A · Grant / award | Common Stock | 1248.0 | 71.17 |
| 2026-04-01 | MORRISON DENISE M | A · Grant / award | Common Stock | 721.0 | 0.0 |
| 2026-04-01 | Kennard William E | A · Grant / award | Common Stock | 721.0 | 71.17 |
| 2026-04-01 | GUTIERREZ CARLOS M | A · Grant / award | Common Stock | 721.0 | 0.0 |
Identity & relationships
SEC issuer · 0001099219METLIFE INC
- Legal Entity Identifier
- C4BXATY60WC6XEOZDX54
- GLEIF legal name
- METLIFE, INC.
- Entity / LEI registration status
- ACTIVE / ISSUED
- Reference data updated
- 2026-01-07T07:13:15Z
Search names and former names
View Wikidata identity and references ↗
- MetLife · alias · wikidata
- Metropolitan Life Insurance Company · alias · wikidata
- Metropolitan · alias · wikidata
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $70.99B | $75.56B |
| 2023-12-31 | $66.91B | $73.32B |
| 2022-12-31 | $68.77B | $78.45B |
| 2021-12-31 | $68.70B | $84.64B |
| 2020-12-31 | $67.84B | $87.53B |
| 2019-12-31 | $69.62B | $90.93B |
| 2018-12-31 | $67.94B | $90.34B |
| 2017-12-31 | $62.31B | $84.88B |